Oral Presentation — ASN Events

Search
Speakers

Therapy induced cellular reprogramming leads to metabolic vulnerabilities before the emergence of permanent acquired drug resistance in BRAF mutant melanoma (#9)

Heinz Hammerlindl ¹ , Dinoop Ravindran-Menon ¹ , Sabrina Hammerlindl ¹ , Elmar Zuegner ² , Joachim Torrano ¹ , Nikolas Haass ¹ , Christoph Magnes ² , Helmut Schaider ¹

Diamantina Institute, The University of Queensland, Brisbane, Queensland, Australia
Institute for Biomedicine and Health Sciences, Joanneum Research Forschungsgesellschaft m.b.H., HEALTH, Graz, Austria

Publish consent withheld

Oral Presentation ASDR-AWTRS-MEPSA 2018 Joint Meeting

Therapy induced cellular reprogramming leads to metabolic vulnerabilities before the emergence of permanent acquired drug resistance in BRAF mutant melanoma (#9)